Renal function change after switching tenofovir disoproxil fumarate for tenofovir alafenamide in the HIV-positive patients of a metropolitan sexual health service

被引：0
|
作者：
Dane Turner
Douglas Drak
Catherine C. O’Connor
David J. Templeton
David M. Gracey
机构：
[1] University of Sydney,Sydney Medical School
[2] University of Sydney,Central Clinical School
[3] RPA Sexual Health,Kirby Institute
[4] Sydney Local Health District,Renal Unit
[5] UNSW Sydney,undefined
[6] Royal Prince Alfred Hospital,undefined
[7] Sydney Local Health District,undefined
来源：
AIDS Research and Therapy | / 16卷
关键词：
Tenofovir disoproxil fumarate; Tenofovir alafenamide; HIV; Renal function;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Renal function change after switching tenofovir disoproxil fumarate for tenofovir alafenamide in the HIV-positive patients of a metropolitan sexual health service
    Turner, Dane
    Drak, Douglas
    O'Connor, Catherine C.
    Templeton, David J.
    Gracey, David M.
    [J]. AIDS RESEARCH AND THERAPY, 2019, 16 (01)
  • [2] SWITCHING FROM TENOFOVIR DISOPROXIL FUMARATE TO TENOFOVIR ALAFENAMIDE: ASSESSING THE CHANGE IN RENAL FUNCTION IN HEPATITIS B PATIENTS
    Lee, Minna
    Lee, Susan M. K.
    Bernstein, David Eric
    [J]. HEPATOLOGY, 2019, 70 : 316A - 316A
  • [3] Summary for Patients: Weight and Metabolic Changes After Switching From Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide in People Living With HIV
    不详
    [J]. ANNALS OF INTERNAL MEDICINE, 2021, 174 (06) : I21 - I21
  • [4] Long-Term Evaluation of Changes in Kidney Function after Switching from Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide in Patients Living with HIV
    Gilbert, Jared M. M.
    Vest, Kirsten
    Kish, Troy D. D.
    [J]. PHARMACY, 2022, 10 (06)
  • [5] Improvement of hepatic fibrosis after tenofovir disoproxil fumarate switching to tenofovir alafenamide for three years
    Huynh, Tung
    Bui, Delana MyAn
    Zhou, Tina Xiwen
    Hu, Ke-Qin
    [J]. WORLD JOURNAL OF HEPATOLOGY, 2024, 16 (07)
  • [6] Bone turnover change after randomized switch from tenofovir disoproxil to tenofovir alafenamide fumarate in men with HIV
    Moore, Amelia E. B.
    Burns, James E.
    Sally, Deirdre
    Milinkovic, Ana
    Krokos, Georgios
    John, Joemon
    Rookyard, Christopher
    Borca, Alessandro
    Pool, Erica R. M.
    Tostevin, Anna
    Harman, Alyss
    Dulnoan, Dwight S.
    Gilson, Richard
    Arenas-Pinto, Alejandro
    Cook, Gary J. R.
    Saunders, John
    Dunn, David
    Blake, Glen M.
    Pett, Sarah L.
    [J]. AIDS, 2024, 38 (04) : 521 - 529
  • [7] Fanconi syndrome due to tenofovir disoproxil fumarate reversed by switching to tenofovir alafenamide fumarate in an HIV-infected patient
    Mothobi, Nomvuyo Z.
    Masters, Jeffrey
    Marriott, Deborah J.
    [J]. THERAPEUTIC ADVANCES IN INFECTIOUS DISEASE, 2018, 5 (05) : 91 - 95
  • [8] Weight changes in patients with sustained viral suppression switching tenofovir disoproxil fumarate to tenofovir alafenamide
    Schafer, Jason J.
    Zimmerman, Matty
    Walshe, Ciara
    Cerankowski, Jesse
    Shimada, Ayako
    Keith, Scott W.
    [J]. OBESITY, 2022, 30 (06) : 1197 - 1204
  • [9] Switching from tenofovir disoproxil fumarate to tenofovir alafenamide fumarate in a cohort of patients with HBV infection: A retrospective study
    Stroffolini, Giacomo
    Dodaro, Valentina
    De Nicolo, Amedeo
    Cusato, Jessica
    Di Perri, Giovanni
    D'Avolio, Antonio
    Boglione, Lucio
    [J]. JOURNAL OF CLINICAL VIROLOGY PLUS, 2024, 4 (01):
  • [10] Retreatment Efficacy and Renal Safety of Tenofovir Alafenamide, Entecavir, and Tenofovir Disoproxil Fumarate After Entecavir or Tenofovir Cessation
    Shao-Ming Chiu
    Kuo-Chin Chang
    Tsung-Hui Hu
    Chao-Hung Hung
    Jing-Houng Wang
    Sheng-Nan Lu
    Chien-Hung Chen
    [J]. Digestive Diseases and Sciences, 2023, 68 : 665 - 675
12345